Pharmaceuticals - Indian - Bulk Drugs
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 16.13 | 12.34 | 11.22 | 11.72 | 16.82 |
Total Expenses | 15.90 | 10.56 | 11.17 | 11.56 | 16.63 |
Profit Before Tax | 0.23 | 1.78 | 0.04 | 0.16 | 0.19 |
Profit After Tax | 0.16 | 1.25 | 0.03 | 0.12 | 0.16 |
Operating Profit after Depreciation | 1.01 | 2.43 | 0.55 | 0.60 | 0.60 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 1.38 | 1.51 | 1.65 | 1.87 | 2.13 |
Total Non Current Assets | 13.79 | 9.62 | 1.65 | 1.92 | 2.17 |
Total Current Assets | 18.62 | 8.05 | 11.91 | 11.97 | 11.83 |
TOTAL ASSETS | 32.40 | 17.68 | 13.56 | 13.89 | 14.01 |
Total Shareholder's Fund | 22.84 | 10.68 | 7.40 | 7.36 | 7.24 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | -5.30 | -1.66 | 0.21 | -1 | -1.46 |
Net Cash used in Investing Activities | 0.32 | -0.03 | - | - | -0.02 |
Net Cash used in Financing Activities | 10.99 | 1.68 | -0.22 | 0.98 | 1.51 |
No data available
Particulars (in ₹ Cr.) | 2023-03 | 2022-12 |
---|---|---|
Total Revenue | - | - |
Total Expenses | - | - |
Profit Before Tax | - | - |
Profit After Tax | -0.04 | 0.73 |
Operating Profit after Depreciation | - | - |
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Vilin Bio Med Ltd | ₹18.45 | ₹25.74 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
06 Jan 2025, 12:56 pm
14 Sep 2024, 10:29 am
17 Aug 2024, 10:21 am
24 May 2024, 01:45 pm
03 Feb 2024, 01:01 pm